GlaxoSmithKline plc (LON: GSK) shares climb on the background of new antibiotic

GlaxoSmithKline has developed a new antibiotic

In brief: GlaxoSmithKline plc (LON: GSK) said the development of new high-quality antibiotic. GlaxoSmithKline shares continue to gain.

GlaxoSmithKline plc (LON: GSK) shares are at around 1,140.00 points in the middle of stock market trading today. GlaxoSmithKline has gained +8.00 points, or 0.71%.

The UK’s largest pharmaceutical company GlaxoSmithKline announced the development of a new antibiotic, which can overcome the resistance of the organism to drugs, complicating treatment received in hospital diseases. It is reported that the drug blocks the enzymes that enable bacteria to reproduce a new way. It is worth noting that the conclusion of a new development GlaxoSmithKline to market will take several years.

Igor Tringlers
2010-08-06 11:41, Economics.

News on: , , , , ,

Post a comment

E-